688068:SHA
Beijing Hotgen Biotech Co Ltd
CNÂ¥77.58
arrow_upward
+0.61%(+0.47) 1D
Oct 14, 3:00:01 PM GMT+8 · CNY
search
All symbols
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for 688068...
Open
CNÂ¥77.04
High
CNÂ¥79.50
Low
CNÂ¥75.09
Mkt. cap
7.15B
Avg. vol.
2.42M
Volume
2.39M
52-wk high
CNÂ¥214.78
52-wk low
CNÂ¥73.44
EPS
-CNÂ¥3.00
No. of employees
1K
Open
CNÂ¥77.04
High
CNÂ¥79.50
Low
CNÂ¥75.09
Mkt. cap
7.15B
Avg. vol.
2.42M
Volume
2.39M
52-wk high
CNÂ¥214.78
52-wk low
CNÂ¥73.44
EPS
-CNÂ¥3.00
No. of employees
1K
News stories
From web sources and news partners
Simply Wall Street
·
8 minutes ago
Palo Alto Networks (PANW) Becomes Founding Partner In Critical Infrastructure Defense Program
Investing News Network
·
25 minutes ago
Oracle NetSuite Announces Launch of AI-first QuickStart: NYSE Content Update
Reuters
·
2 hours ago
Wall St opens lower after hot CPI data fuels rate-hike bets
Profile
Hotgen Biotech, often simply referred to as Hotgen, is a Chinese biological technology company founded in 2005. It focuses on the manufacture of in-vitro diagnostic instruments and reagents. In September 2019, the company was listed on the Shanghai Stock Exchange. During the novel coronavirus pandemic, it specialized in making 2019-nCoV antigen diagnostic products, which obtained EU CE certification.
Hotgen was formerly a constituent of the STAR 50 Index. Headquartered in Beijing, it also established presences in foreign markets, such as the United Kingdom, France, and Germany. The net profit of the company in 2021 exceeded 2.3 billion yuan, an increase of more than sixteen times from the previous year. In 2022, its RAT kits were distributed free of charge by the Hong Kong Government to the public. In November 2023, it attended the MEDICA Trade Fair in Düsseldorf. Wikipedia
About Beijing Hotgen Biotech Co Ltd